ANI Pharmaceuticals announced the results of the NEW DAY clinical trial for ILUVIEN® (fluocinolone acetonide) in diabetic macular edema (DME) patients during the ASRS Annual Scientific Meeting. The ...
Please provide your email address to receive an email when new articles are posted on . The NEW DAY study did not meet its primary endpoint but showed good outcomes in secondary endpoints. A post hoc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results